10 employees
Vascugen is a biotechnology company developing regenerative medicine for treatment of intractable vascular diseases.
2017
$835K
from 1 investors over 1 rounds
Vascugen raised $835K on November 16, 2018
Investors: Indiana Philanthropic Venture Fund (IU PhV)